Chronic antithrombotic therapy in post-myocardial infarction patients

Cardiology Clinics
Rangadham NagarakantiMichael Ezekowitz

Abstract

Because 1.1 million myocardial infarctions occur in the United States alone each year, and 450,000 of them are recurrent infarctions, which carry an inherently greater risk of death and disability than first events, the importance of secondary prevention strategies that can be implemented widely is unparalleled in health care. Antithrombotic therapies, both antiplatelet and anticoagulant, have become the mainstays of these strategies. This article covers the use of chronic antiplatelet and anticoagulation agents after myocardial infarction. It does not include the management of these patients in the acute phase.

References

Jan 23, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Jan 1, 1991·Annals of the New York Academy of Sciences·B S CollerD Knight
Oct 9, 1986·The New England Journal of Medicine·C T ShermanL Morgenstern
Nov 28, 1985·The New England Journal of Medicine·J A CairnsM G Myers
Jan 1, 1986·The American Journal of Cardiology·A K GashR D Gentzler
Jun 8, 1995·The New England Journal of Medicine·J LefkovitsE J Topol
May 5, 1994·The New England Journal of Medicine·C Patrono
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Jul 20, 2002·Lancet·Robert F van EsUNKNOWN Antithrombotics in the Secondary Preventionof Events in Coronary Thrombosis-2 (ASPECT-2) Research Group
Sep 27, 2002·The New England Journal of Medicine·Mette HurlenHarald Arnesen
Oct 12, 2002·BMJ : British Medical Journal·David A FitzmauriceGregory Y H Lip
Feb 14, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ulf G ErikssonDavid Gustafsson
May 14, 2003·European Journal of Clinical Pharmacology·Ulf G ErikssonDavid Gustafsson
Oct 2, 2003·The Annals of Pharmacotherapy·Azzah S Jeddy, Brenda L Gleason

❮ Previous
Next ❯

Citations

Apr 2, 2013·Trends in Cardiovascular Medicine·Robert Flaumenhaft
Jan 25, 2011·Cardiology Clinics·Kumaran Kolandaivelu, Deepak L Bhatt
Mar 29, 2014·Circulation Research·Bruce Furie, Robert Flaumenhaft

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.